T follicular helper cells in HIV infection

Slides:



Advertisements
Similar presentations
Antiretroviral Drug Resistance
Advertisements

Antiretroviral Drug Resistance Anna Maria Geretti UCL Medical School & Royal Free Hampstead Medical School, London.

Kuala Lumpur, July 2nd 2013 The ANRS International VISCONTI Post Treatment Controller Cohort.
ARV overview and toxicity Dr Francois Venter Reproductive Health Research Unit University of the Witwatersrand.
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Interactive Workshop “HIV Cure 101”: Challenges in identifying and targeting the HIV reservoir Sarah Palmer Centre for Virus Research Westmead Millennium.
The role of HIV infection and Co-infections in Serious Non-AIDS Events Peter W. Hunt, M.D Associate Professor of Medicine, UCSF.
HIV 101 Review Evaluation Center for HIV and Oral Health Boston University School of Public Health Health & Disability Working Group.
Controversies in HIV Cure Research Debate 1. Is there ongoing replication under HAART? Mario Stevenson and Frank Maldarelli Moderator: Steve Deeks.
Lecture outline The nomenclature of Immunology Types of immunity (innate and adaptive; active and passive; humoral and cell- mediated) Features of immune.
Lecture outline The nomenclature of Immunology
Marian Kerbleski, RN UCSF AIDS Division San Francisco General Hospital.
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup, MD.
David M. Margolis, MD Professor of Medicine Towards an HIV cure: medical, social and ethical challenges in research and testing.
An Introduction to the HIV Problem Space Oakwood University: Faculty Quantitative Institute Aug. 10–12, 2009.
HIV: Acute (Primary) Infection. David H
HIV, CD4, and More Karen Hutcherson Jenn Mann Elizabeth McCauley Michael Powers Courtney Wilson.
Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution.
Myeloid cells matter Conclusions. Glut1+ CD14++ CD16+ Associated with inflammatory markers HIV Immune activation HIV-related diseases Joshua Anzigen:
Immune correlates of unusual control of viral replication after cessation of HAART Ellen Van Gulck 1, Leo Heyndrickx 1, Céline Merlin 1, Sandra Coppens.
Slide 1 of 11 From DA Wohl, MD, at New York, NY: May 03, 2012, IAS-USA. IAS–USA David Alain Wohl, MD Associate Professor of Medicine The University of.
Chapter 17: HIV/AIDS. HIV/AIDS -HIV: Human Immunodeficiency Virus -AIDS: Acquired Immunodeficiency Syndrome -AIDS represents the end stage of infection.
Characterization of persistent HIV-1 in a broad spectrum of CD4 + T-cells isolated from peripheral blood, bone marrow, lymphoid tissue and gut associated.
1 Modelling the interactions between HIV and the immune system in hmans R. Ouifki and D. Mbabazi 10/21/2015AIMS.
Poster # 388 CROI Feb Montreal, Canada Association of HIV-1 Co-receptor Tropism with Immunologic and Virologic Parameters in HIV-1 infected,
A new molecular mechanism for HIV-1 latency HIV latency in primary T cells: natural activation/purging by DCs Ben Berkhout Academic Medical Center University.
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA.
Functional cure after long term HAART initiated during early HIV infection - a case study. van Lunzen J. 1,2, Schulze zur Wiesch J. 1,2, Schumacher U.
Learning About an HIV Cure by Doing Studies in HIV+ Subjects Alan Landay, PhD Professor and Chairman Department of Immunology/Microbiology Rush University.
Persistent immune activation despite suppressive HAART is associated with higher risk for viral blips in HIV-1 infected individuals Alexander Zoufaly 1.
Chelsea Harmon Catherine Hanson Abby Llaneza Jen Williams
Enfuvirtide for Drug-Resistant HIV Infection in North and South America Simon R. Bababeygy.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
HIV: Science, Sex and Society. Lecture 1. Mechanisms of viral persistence in the face of antiviral therapy. Mario Stevenson, Ph.D Department of Medicine.
BIT225 Reduces the Intracellular HIV-1 Burden Within Monocyte Derived Dendritic Cells, Resulting in Reduced Transfer of Virus to more Permissive CD4 +
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Antiretroviral Therapy on Viral Load, CD4.
The Dynamics of HIV RNA, CD4+ Count and Mycobacterium tuberculosis (Mtb) Antigen Specific Cytokines in TB/HIV Patients Following Successful Tuberculosis.
Alexander Pasternak Laboratory of Experimental Virology, Department of Medical Microbiology Academic Medical Center of the University of Amsterdam Amsterdam,
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
Copyright © 2010 American Medical Association. All rights reserved.
Rapporteur Report – Track A Basic and Translational Sciences
HIV Cure: Current Status and Future Perspectives
Higher rate of antiretroviral therapy reinitiation among HIV-HBV coinfected patients in the episodic arm of the SMART study Dore G.1, Soriano V.2, Neuhaus.
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort.
HEATHER Feedback Meeting
Human Health and Disease
Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana ¹Obiri-Yeboah Dorcas, School of Medical Sciences,
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Location of IL‐17‐producing cell types.
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Expression of CD36 and psap in a TMA of human ovarian cancer patients
Figure 6 Laquinimod treatment of spontaneous EAE prevents progression and reduces the frequency of Tfh cells Laquinimod treatment of spontaneous EAE prevents.
Immunological phenotypes of CD4+ T cells preferentially infected by HIV. PBMCs exposed to HIV-1BaL (MOI 0.01) were cultured for 10 d. Immunological phenotypes.
NKTeeing Up B Cell Responses to Viral Infection
New developments in laboratory monitoring of HIV-1 infection
Molecular virology and immunology of HIV infection
Fig. 2 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART results in successive increases in elongated, polyadenylated, and.
Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection  Lin Shen, MD, Robert F. Siliciano,
Figure 1 Laquinimod treatment reduces the frequency of Tfh cells and IL-21–producing T cells in rMOG-induced EAE Laquinimod treatment reduces the frequency.
(A) Haematoxylin and eosin stained section of multicentric Castleman's disease in a human immunodeficiency virus (HIV) positive patient showing a high.
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection  Saurabh Mehandru, MD, Klara Tenner-Racz, MD, Paul Racz, MD, PhD, Martin.
CD8 T cell memory alters the immune profile in enhanced HLH without altering viral load. CD8 T cell memory alters the immune profile in enhanced HLH without.
Replication and intercellular transmission of HIV-1 is increased during antigen presentation. Replication and intercellular transmission of HIV-1 is increased.
Fig. 3 Viral loads and viral DNA in anti-α4β7 antibody–treated rhesus macaques that initiated ART during chronic SIVmac251 infection (study 2). Viral loads.
Fig. 5 LASV replication in cynomolgus monkeys.
Relationship between darunavir IQ and the probability of virologic success (HIV-1 RNA
Presentation transcript:

T follicular helper cells in HIV infection Jan van Lunzen University Medical Center Hamburg-Eppendorf Heinrich-Pette-Institut for Experimental Virology & Immunology Hamburg, Germany

Outline/Questions Where does HIV replicate in LN? Which cells are preferentially infected? What effect/limitations does HAART have? What is the role of T follicular helper cells in HIV infection? Are TFH cells a viral reservoir? What are the consequences of dysregulated TFH function? Can these functions be restored?

Where does HIV replicate in lymph nodes?

Lymph Node Pathology HIV - HIV + Stellbrink & van Lunzen, Curr Opin Infect Dis 2001

Immunopathology of LN CD4+Ki-67+ CD8+ Tenner-Racz K, Stellbrink HJ, van Lunzen J et al., J Exp Med 1998

Which cells are preferentially infected?

Infection rate of CD57+ and CD57- CD4+ T cells in PB and LN LN CD57+CD4+ T cells LN CD57–CD4+ T cells PBL CD57+CD4+ T cells PBL CD57–CD4+ T cells 10 7,5 Infected cells (%) 5 2,5 Patient no. 1 2 3 5 7 Ratio of the viral loads: CD57+CD4+ T cells [%]/CD57– CD4+ T cells [%] LN: 10.5 3.3 8.0 9.5 3.0 PBL: 0.3 2.2 <0.1 2.5 2.5 Hufert F, van Lunzen J et al.: AIDS 1997

What effect/limitations does HAART have?

HIV-1 RNA in LN during HAART Day 0 Day 28 HIV-1 RNA p24 Ag Tenner-Racz K, Stellbrink HJ, van Lunzen J et al., J Exp Med 1998 van Lunzen J, Ruiz L et al., AIDS 1998

T cell proliferation in LN during HAART 15% 10% 5% pre-treatment (n = 30) post-treatment (n = 30) normal controls (n = 4) p < 0,0001 p < 0,0001 CD4+Ki-67+ CD8+Ki-67+ van Lunzen J, et al., CROI 1999

What is the role of T follicular helper cells in HIV infection?

CD4 TFH cells are critical for effective antibody responses Plasma cell B cell CD4 TFH cells MHC II TCR PD-1 CXCR5 Memory B cell CD40L CD40 Bcl6 Bcl6 ICOSL ICOS IL-21 IFNγ IL-4 We have known for a long time the importance of CD4 T cell help to B cells for induction of proliferation, somatic hypermutation, class switching and memory formation. During the last decade these Cd4 T helper cells have been recognized as a new lineage, termed t follicular helper cells. They have been described as reciding in the B cell follicle, due to high expression of CXCR5. They are PD1and ICOS positive, express the transcription factor Bcl6 and secrete IL21. Given the importance of TFh cells in inducing and regulating B cell responses, it is surprising that nothing is currently known about TFH cells in HIV infection. So the question that we asked ourselves was: Within the follicle Express CXCR5, PD1, ICOS Bcl6+ IL-21 (cardinal cytokine) B cell proliferation Antibody maturation (SHM) Class switching (CSR) Memory development 12

SIV: Relative Accumulation of TFH in LN SIV acute SIV chronic (high % of TFH) SIV- SIV chronic (low % of TFH) % of CM CD4 T cells p=0.0008 p<0.0001 PD-1 CCR7 10 3 4 5 2 ICOS CD150 Petrovas C. et al. JCI 2012 13

Chronic SIV (>2 months) SIV Gag DNA (copies/cell) Immune activation rather than direct infection with SIV is associated with in vivo TFH accumulation Chronic SIV (>2 months) p=0.0013 p=0.0004 p=0.0164 sCD14 (x106 pg/ml) 0.5 1.0 1.5 SIV Gag DNA (copies/cell) SIV acute SIV chronic (high % of TFH) SIV- SIV chronic (low % of TFH) PD-1 CCR7 10 3 4 5 2 ICOS CD150 Petrovas C. et al. JCI 2012 14

SIV-specific IgG (titer, x104) Accumulation of TFH is Associated with Increased Frequency of GC-B cells and titers of SIV-specific Antibodies SIV acute SIV chronic (low % TFH) SIV chronic (high % TFH) p=0.0286 PNAhighIgGlow PNAhighIgGhigh 10 7.5 SIV-specific IgG (titer, x104) p=0.051 p=0.048 p=0.033 5 2.5 ND ND ND ND ND SIV - SIV + low % TFH SIV + high % TFH gp120 gp130 gp140 p27 p55 Petrovas C. et al. JCI 2012 15

High frequency of CXCR5+PD-1high CD4 T cell subset in the lymph node The frequency of this CD4 T cell subset was 100 fold higher in LN compared to in the periphery we further verified the lineage commitment by staining for Bcl6, Lindqvist M et al., JCI 2012 16

IL-21 preferentially produced by TFH cells Further, we could show that IL21, which is a cardinal cytokine of Tfh cells and has been shown to regulate B cell diffrentitation, proliferation and subsequently GC responseswas mainly produced by TFH cell subset With the selective depletion of CD4 T cells in HIV infection, we were interested in looking at the effect of HIV on TFH cells Lindqvist M et al., JCI 2012 17

Expansion of TFH cells correlated with skewing of B cell subsets GC B cells Plasma B cells Late memory B cells Interestingly, we could detect strong correlations could be between the increase of GC B and PCs with Tfh cell frequency. The loss of memory B cells could also be strongly correlated to the increase of TFh cells. Indicating a contribution of TFh cells in the skewing of B cell phenotypes in HIV infection Lindqvist M et al., JCI 2012 18

Hypersecretion of IgG was associated with BCL6 expression in TFH cells Given the significant changes observed in the B cell compartment, we next determined if the expansion of TFH cells is associated with hypergammaglobulinemia Interestingly, We could detect a strong correlation between the Bcl6 expression in TFH cells and IgG levels in the sera, this association was mainly driven by IgG1 which constituted 70% of the secreted IgG antibodies in these patients. Lindqvist M et al., JCI 2012 19

Are TFH cells a viral reservoir?

PTEs (Gag, Pol, Env)+α-CD28 TFH Cells and CXCR5-PD-1+ CD4 T-Cells Are Enriched in HIV-Specific CD4 T-Cells PTEs (Gag, Pol, Env)+α-CD28 Brefeldin A LNMCs Intracellular staining Aqua, CD3, CD4, CD8, CD45RA, CXCR5, PD1, IL-21, IL-2, TNF-α, IFN-γ Perreau M et al JEM 2012

TFH Cells and CXCR5-PD-1+ CD4 T-Cells Are Enriched in CD4 T-Cells Containing HIV DNA DNA extraction Taqman RT-PCR HIV-1 gag gene Perreau M et al JEM 2012

(>15000 HIV RNA copies/mL) TFH Cells and CXCR5-PD-1+ CD4 T-Cells Are the Most Efficient in Supporting Production of HIV Anti-CD3/CD28 Collection of SNs p24 detection D0 D2 D5 High viremia (>15000 HIV RNA copies/mL) Perreau M et al JEM 2012

Low viremia (<1000 HIV RNA copies/mL) HIV Isolation from Patients with Low (<1000 HIV RNA copies/mL of plasma) in Different CD4 T-Cell Populations Collection of SNs CD8-depleted PBMCs + Coated CD3/28 p24 detection D0 D3 D7 Low viremia (<1000 HIV RNA copies/mL) TFH and CXCR5-PD-1+ but not CXCR5-PD-1- and CXCR5+PD-1- CD4 T-cells efficiently support virus isolation and production in patients with low viremia levels

What are the consequences of dysregulated TFH function?

PD-L1 expression in GC B cells Cubas RA et al. Nature Med. 2013

PD-1 ligand and TFH proliferation, activation and cytokine secretion Cubas RA et al. Nature Med. 2013

PD-1 Triggering affects TFH function ICOS MFI P = 0.009 P = 0.025 IL-21 pg/ml Absolute number ICOS+ Tfh cells Cubas RA et al. Nature Med. 2013 29

Can these functions be restored?

Exogenous IL-21 enhances TFH function P < 0.03 P < 0.03 IgG (ng/ml) IgG (ng/ml) -IL-21 +IL21 HIV- LN HIV+ LN P < 0.02 P < 0.02 P < 0.02 CD27 MFI (B cells) CD27 MFI (B cells) -IL-21 +IL21 -IL21 +IL21 +IL21 (10ng/ml) (40ng/ml) HIV+ LN

(Gag-Env stimulation) (Gag-Env stimulation) Enhancing HIV-specific TFH function by interfering with PD-1/IL-21 axis Total IgG (ng/ml) Total IgG (ng/ml) -IL-21 +IL21 Isotype αPD-L1/L2 HIV+ LN (Gag-Env stimulation) HIV+ LN (Gag-Env stimulation) Cubas RA et al. Nature Med. 2013

Hypothesis model Plasma cell Memory B cell Germinal center B cell HIV viremia IL-21 Based on our data we propose a model for B cell dysfunction in HIV infection that is not based on lack of CD4 T cell help, but rather that persistent viremia drive an abnormal expansion of TFH cells We believe that TFH cells stimulate GC B cells, we don’t know today what directs development of GC B cells into memory B cells or plasma cells. The loss of memory B cells could be due to some fucntional loos of the TFH cells. It is also known that IL-21 induce immunoglobulin secreting cells, which might drive antibody secretion This is however something that needs to be studied further. Plasma cell TFH B cell follicle Lymph node 33

Summary I HIV-specific TFH cells are expanded in chronic infection Expansion of TFH cells correlated with skewing of B cell subsets in chronic HIV infection Hypersecretion of IgG1 was associated with BCL6 expression in TFH cells TFH serve as a viral reservoir and promote HIV replication So to summarize: We were able to detect an increase of CXCR5+,PD1high TFH cells in LN of chronic HIV infected patients The observed expansion of Tfh cells correlated with an a skewing of the B cell phenotypes towards GC B cells an PCs, with loss of Memory B cells And we could also see that hypersecretion of IgG and IgG1 was associated with the Bcl6 expression in TFH cells in chronic HIV infection 34

Summary II B memory cell responses are skewed in HIV infection PD-L1 is overexpressed on B cells in HIV infection and down regulates TFH function TFH and B cell function can be restored by anti-PD-1 and/or exogenous II-21 TFH cells may represent the primary obstacle for achieving functional HIV cure So to summarize: We were able to detect an increase of CXCR5+,PD1high TFH cells in LN of chronic HIV infected patients The observed expansion of Tfh cells correlated with an a skewing of the B cell phenotypes towards GC B cells an PCs, with loss of Memory B cells And we could also see that hypersecretion of IgG and IgG1 was associated with the Bcl6 expression in TFH cells in chronic HIV infection 35

Pathogenesis Model Vinuesa CG, JCI 2012

O. Degen J. Schulze zur Wiesch S. Hertling I. Toth A. Hüfner S. Schmiedel J. Schulze zur Wiesch I. Toth P. Hartjen S. Kummer Now to the most important part of my talk: First I want to thank my team from the HIV Labor at the university of hamburg, my supervisor Jan van Lunzen and my guardian Julian Schulze zu Wiesch for their financial and intellectual support and their patience with me, for the assistence and emotional support I thank Kristina Colberg, Silke Kummer and Philip Hartjen. I also thank the team of the department of infectious diseases of the University of Hamburg for their zealous collecting of patients blood. I thank Joachim Hauber from the HPI for his cooperation and support of my work, Dirk Meyer Olson and his PhD student Phillip Keudel from Hannover, who helped me to get enough PBMC of HIV-progressive patients, Gerd Fätkenheuer and Clara Lehmann from cologne for their help with nonprogressive patients. And most of all I thank the patients for their blood donation......... and you for your attention!

Slides and data provided by: O. Degen S. Hertling A. Hüfner S. Schmiedel J. Schulze zur Wiesch I. Toth P. Hartjen S. Kummer Slides and data provided by: C. Petrovas, R. Koup (VRC, NIH, USA) M. Lindqvist, H. Streeck (Ragon Inst., MGH, Boston, USA) M. Perreau, G. Pantaleo (Univ. of Lausanne, Switzerland) R. Cubas, E. Haddad (VGTI, Florida, USA) Now to the most important part of my talk: First I want to thank my team from the HIV Labor at the university of hamburg, my supervisor Jan van Lunzen and my guardian Julian Schulze zu Wiesch for their financial and intellectual support and their patience with me, for the assistence and emotional support I thank Kristina Colberg, Silke Kummer and Philip Hartjen. I also thank the team of the department of infectious diseases of the University of Hamburg for their zealous collecting of patients blood. I thank Joachim Hauber from the HPI for his cooperation and support of my work, Dirk Meyer Olson and his PhD student Phillip Keudel from Hannover, who helped me to get enough PBMC of HIV-progressive patients, Gerd Fätkenheuer and Clara Lehmann from cologne for their help with nonprogressive patients. And most of all I thank the patients for their blood donation......... and you for your attention!